Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Gilead Sciences
Genmab
National Institutes of Health Clinical Center (CC)
Newave Pharmaceutical Inc
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
MacroGenics
M.D. Anderson Cancer Center
Acerta Pharma BV
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
National Institutes of Health Clinical Center (CC)
AstraZeneca
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Scripps Health
University of California, Davis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Jaeb Center for Health Research
Xencor, Inc.
Astellas Pharma Inc
University of Giessen
University of Giessen
Mustang Bio
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
Novartis
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Power Life Sciences Inc.
Thomas Jefferson University
Aziende Chimiche Riunite Angelini Francesco S.p.A
Northwestern University
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center